Loading...
•
Mar 31, 2020
OrthoPediatrics Q1 2020 Earnings Report
OrthoPediatrics reported an 11.6% increase in total revenue and a 30.4% increase in domestic revenue for Q1 2020.
Key Takeaways
OrthoPediatrics Corp. announced its financial results for the first quarter ended March 31, 2020, reporting a total revenue of $16.4 million, up 11.6% from $14.7 million in the first quarter of 2019. The company saw strong domestic revenue growth of 30.4% and continued to advance its strategic initiatives, including the acquisition of ApiFix and the launch of new products.
Total revenue for first quarter 2020 was $16.4 million, up 11.6% from first quarter 2019.
Domestic revenue growth was 30.4% for the first quarter 2020.
Acquired ApiFix and MID-C system on April 1st, expanding portfolio of novel technologies to treat scoliosis.
Expanded the domestic sales organization to 167 consultants, up 21.0% from first quarter 2019.
OrthoPediatrics
OrthoPediatrics
OrthoPediatrics Revenue by Segment
OrthoPediatrics Revenue by Geographic Location
Revenue by Segment
Trauma & Deformity Revenue
CapyFin.comScoliosis Revenue
CapyFin.comSports Medicine/Other Revenue
CapyFin.comRevenue by Geographic Location
U.S. Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
Due to the rapidly evolving environment and continued uncertainties surrounding the duration and impact of COVID-19, OrthoPediatrics maintains suspension of its revenue growth and set consignment guidance for the full year 2020.
Revenue & Expenses
Visualization of income flow from segment revenue to net income